GLENMEDE TRUST CO NA - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q3 2020$0240.0%0.00%
Q2 2020$0240.0%0.00%
Q1 2020$0240.0%0.00%
Q4 2019$0
-100.0%
24
-97.7%
0.00%
Q3 2019$6,0000.0%1,0240.0%0.00%
Q2 2019$6,000
-14.3%
1,0240.0%0.00%
Q1 2019$7,000
+75.0%
1,0240.0%0.00%
Q4 2018$4,0000.0%1,024
+2.4%
0.00%
Q1 2018$4,0000.0%1,0000.0%0.00%
Q4 2017$4,000
-55.6%
1,0000.0%0.00%
Q3 2017$9,000
-25.0%
1,0000.0%0.00%
Q2 2017$12,0000.0%1,0000.0%0.00%
Q1 2017$12,0000.0%1,0000.0%0.00%
Q4 2016$12,000
-7.7%
1,000
-9.3%
0.00%
Q3 2016$13,000
+62.5%
1,103
+10.3%
0.00%
Q2 2016$8,000
+60.0%
1,0000.0%0.00%
Q1 2016$5,000
-28.6%
1,0000.0%0.00%
Q4 2015$7,0000.0%1,0000.0%0.00%
Q3 2015$7,000
-22.2%
1,0000.0%0.00%
Q2 2015$9,000
-25.0%
1,0000.0%0.00%
Q1 2015$12,000
-7.7%
1,0000.0%0.00%
Q4 2014$13,000
+62.5%
1,0000.0%0.00%
Q3 2014$8,000
-38.5%
1,0000.0%0.00%
Q2 2014$13,000
+44.4%
1,0000.0%0.00%
Q1 2014$9,000
-30.8%
1,0000.0%0.00%
Q4 2013$13,000
+8.3%
1,0000.0%0.00%
Q3 2013$12,000
+20.0%
1,0000.0%0.00%
Q2 2013$10,0001,0000.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders